Education
About Us
Working with TipRanks
Follow Us
Bio-Path Holdings (BPTH)
OTHER OTC:BPTH
Total Valuation
Bio-Path Holdings has a market cap or net worth of $536.04K. The enterprise value is $1.02M.
Market Cap$536.04K
Enterprise Value$1.02M
Share Statistics
Bio-Path Holdings has 9,242,151 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,242,151
Owned by Insiders―
Owned by Institutions2.73%
Financial Efficiency
Bio-Path Holdings’s return on equity (ROE) is -64.25 and return on invested capital (ROIC) is -1787.18%.
Return on Equity (ROE)-64.25
Return on Assets (ROA)-2.55
Return on Invested Capital (ROIC)-1787.18%
Return on Capital Employed (ROCE)-20.39
Revenue Per Employee0.00
Profits Per Employee-989.40K
Employee Count10
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bio-Path Holdings is ―. Bio-Path Holdings’s PEG ratio is 0.00321.
PE Ratio―
PS Ratio0.00
PB Ratio18.09
Price to Fair Value18.09
Price to FCF-0.26
Price to Operating Cash Flow-0.11
PEG Ratio0.00321
Income Statement
In the last 12 months, Bio-Path Holdings had revenue of 0.00 and earned -9.89M in profits. Earnings per share was -4.12.
Revenue0.00
Gross Profit-159.00K
Operating Income-11.99M
Pretax Income-9.89M
Net Income-9.89M
EBITDA-9.73M
Earnings Per Share (EPS)-4.12
Cash Flow
In the last 12 months, operating cash flow was -4.48M and capital expenditures 0.00, giving a free cash flow of -4.48M billion.
Operating Cash Flow-4.48M
Free Cash Flow-4.48M
Free Cash Flow per Share-0.48
Dividends & Yields
Bio-Path Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.32
52-Week Price Change-92.37%
50-Day Moving Average0.07
200-Day Moving Average0.12
Relative Strength Index (RSI)47.85
Average Volume (3m)24.92K
Important Dates
Bio-Path Holdings upcoming earnings date is Mar 6, 2026, TBA (Confirmed).
Last Earnings DateNov 14, 2025
Next Earnings DateMar 6, 2026
Ex-Dividend Date―
Financial Position
Bio-Path Holdings as a current ratio of 1.15, with Debt / Equity ratio of -5.98%
Current Ratio1.15
Quick Ratio1.15
Debt to Market Cap0.00
Net Debt to EBITDA0.11
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bio-Path Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bio-Path Holdings EV to EBITDA ratio is -0.17, with an EV/FCF ratio of -0.16.
EV to Sales0.00
EV to EBITDA-0.17
EV to Free Cash Flow-0.16
EV to Operating Cash Flow-0.16
Balance Sheet
Bio-Path Holdings has $0.00 in cash and marketable securities with $479.00K in debt, giving a net cash position of -$479.00K billion.
Cash & Marketable Securities$0.00
Total Debt$479.00K
Net Cash-$479.00K
Net Cash Per Share-$0.05
Tangible Book Value Per Share$0.06
Margins
Gross margin is 3.80%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin3.80%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bio-Path Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast88.04%